Project Details
Project Description
Rapid Response Technology (RaRtech) is a foundational, broadly applicable platform
developed at MIPS. It produces highly active mRNA molecules much faster than any other
method currently in use. RaRtech advantageous speed and dose-reduction are essential for
pandemic preparedness and future therapeutics. This project aims to optimise and scale-up
RaRtech to strengthen our national ability to respond to health challenges now and in the
future.
developed at MIPS. It produces highly active mRNA molecules much faster than any other
method currently in use. RaRtech advantageous speed and dose-reduction are essential for
pandemic preparedness and future therapeutics. This project aims to optimise and scale-up
RaRtech to strengthen our national ability to respond to health challenges now and in the
future.
| Short title | RaRtech technology |
|---|---|
| Status | Finished |
| Effective start/end date | 21/10/22 → 20/01/25 |
Funding
- mRNA Victoria: A$427,000.00
- Monash University – Internal Faculty Contribution
Keywords
- mRNA
- manufacturing
- PCR